Evaluation of the Safety and Effectiveness of the Globe® Pulsed Field System for Treating Patients With Symptomatic Paroxysmal Atrial Fibrillation

This study will evaluate the long-term safety and effectiveness of the Globe® Pulsed Field System for treating patients with symptomatic paroxysmal atrial fibrillation.

Key Inclusion Criteria: * A diagnosis of recurrent symptomatic paroxysmal atrial fibrillation * Failure or intolerance of at least one antiarrhythmic drug (AAD) Class I or III Key Exclusion Criteria: * Persistent or long-standing persistent atrial fibrillation (continuous atrial fibrillation that is sustained \>12 months) * Atrial fibrillation secondary to a reversible cause or of non-cardiac origin * History of thromboembolic events within the past six months * Myocardial infarction (MI)/percutaneous coronary intervention (PCI) within the last three months * Any cardiac surgery within the previous six months * Prior left atrial ablation or surgical procedure * Presence of any pulmonary vein stents * Body mass index (BMI) \>40 kg/m\^2 * Left ventricular ejection fraction (LVEF) \55mm